Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

People with atopic dermatitis are more likely to develop other skin conditions due to shared genetics and immune pathways.

Arctiin helps protect hair cells from damage and death caused by oxidative stress.

Changthangi goats have specific genes that help produce Pashmina wool.

Baricitinib and deuruxolitinib are effective for treating alopecia areata, but their efficacy depends on the dose.

CCCA involves immune response and metabolism issues, suggesting new treatment options.

The research provides a gene-based framework for hair biology, highlighting the Hippo pathway's importance and suggesting links between hair disorders, cancer pathways, and the immune system.

Mathematical modeling helps understand and predict the MAPK cell signaling pathway.

New treatments for vitiligo may focus on protecting melanocyte stem cells from stress and targeting specific pathways involved in the condition.

Tofacitinib and baricitinib are effective and safe for treating severe alopecia areata, especially in younger people.

JAK-inhibitors for alopecia areata are generally safe with mostly mild side effects and a low rate of treatment withdrawal.

Topical tofacitinib is a safe and effective treatment for autoimmune skin disorders.

A new mutation in the TMEM173 gene and a risk allele in IFIH1 cause a unique set of immune-related symptoms.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

MicroRNAs can help regenerate hair by influencing stem cells and immune responses, but delivery challenges exist.

Genetics can help tailor treatments for male pattern hair loss, improving outcomes like stabilization or modest regrowth.

Early diagnosis and targeted anti-inflammatory treatments can improve outcomes in androgenetic alopecia with perifollicular inflammation and fibrosis.

Alopecia is caused by various factors, and new treatments like gene editing and regenerative medicine offer hope for personalized hair regrowth solutions.

Recognizing and treating related skin conditions can improve atopic dermatitis management.

Early intervention in patch-type alopecia may prevent progression to more severe forms by targeting immune pathways and preserving keratin.

JAK inhibitors effectively regrow hair in children with alopecia areata and are safe to use.

An imbalanced scalp microbiome may worsen alopecia areata severity and inflammation, but treatment can partially restore balance.

Stem cells show promise for hair regrowth, but challenges remain.

Alopecia areata treatment should be personalized, using topical or systemic therapies based on severity, with promising options like JAK inhibitors needing more research.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

AP-2α and AP-2β proteins are essential for healthy adult skin and hair.

No cure exists for alopecia areata, and treatments are personalized.

The study found that certain genes are important for hedgehog skin appendage development and immunity, with spines possibly evolving for protection and infection resistance.

Non-coding RNAs play key roles in the hair growth cycle of Angora rabbits.

Moracin M helps hair grow by activating specific pathways and improving blood vessel formation.